Loading company…
Valneva SE is a Saint-Herblain, France vaccine company developing and commercializing vaccines for infectious diseases.
Founded in 1999 and headquartered in Saint-Herblain, France, Valneva SE develops, manufactures and commercializes vaccines for infectious diseases. Its licensed portfolio includes IXCHIQ®, a single-shot chikungunya vaccine, and candidates for Lyme disease, Shigella and Zika. On August 17, 2023 the company raised USD 50 mn in venture debt from Deerfield Management and OrbiMed Advisors. In 2022 it reported revenue of USD 120,972,951.90.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in